Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-09 Purchase | 2025-04-11 9:57 pm | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 934,258 | $10.13 | $9,464,512 | 5,446,072 (Indirect) | View |
| 2024-01-04 Sale(A) | 2025-01-24 4:15 pm | Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER | 40,000 | $45.29 | $1,811,600 | 0 (Direct) | View |
| 2024-08-13 Sale | 2024-08-15 5:06 pm | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) | View |
| 2024-08-13 Sale | 2024-08-15 5:01 pm | Keros Therapeutics Inc. | KROS | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director | 250,000 | $44.01 | $11,002,500 | 119,522 (Indirect) | View |
| 2023-11-04 Sale | 2024-01-08 4:43 pm | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $45.29 | $1,811,600 | 53,622 (Direct) | View |
| 2023-06-08 Sale | 2023-06-12 4:13 pm | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $46.61 | $1,864,239 | 207,244 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-16 Expired | 2025-06-12 4:51 pm | 2025-02-27 2025-05-16 | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 1,314 | $0 | 0 (Indirect) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 15,750 | $0 | 591,242 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 15,750 | $0 | 1,034,484 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 15,750 | $0 | 4,647,819 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 15,750 | $0 | 15,750 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | Nussbaum Ran Director 10% Owner | 15,750 | $0 | 4,647,819 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | Seth Alpna Director | 15,750 | $0 | 15,750 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | GRAY MARY ANN Director | 15,750 | $0 | 15,750 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:15 pm | N/A 2035-06-03 | Keros Therapeutics Inc. | KROS | BIENAIME JEAN JACQUES Director | 15,750 | $0 | 15,950 (Direct) | View |
| 2025-04-09 Other | 2025-04-11 9:57 pm | N/A N/A | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 899,333 | $0 | 5,446,072 (Indirect) | View |
Ownership | 2025-04-11 8:58 pm | N/A N/A | Keros Therapeutics Inc. | KROS | ADAR1 Capital Management LLC ADAR1 Partners LP ADAR1 Capital Management GP LLC Schneeberger Daniel 10% Owner | 0 | $0 | 5,539,139 (Indirect) | View |
| 2025-04-04 Exercise | 2025-04-07 4:15 pm | N/A 2028-03-25 | Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER | 49,367 | $0 | 554,667 (Direct) | View |
| 2025-04-04 Exercise | 2025-04-07 4:15 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER | 49,367 | $0.3 | 554,667 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-19 4:15 pm | N/A N/A | Keros Therapeutics Inc. | KROS | CHYUNG YUNG H. Chief Medical Officer | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-19 4:15 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-19 4:15 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Rovaldi Christopher Chief Operating Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-01-04 Exercise(A) | 2025-01-24 4:15 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER | 40,000 | $16 | 0 (Direct) | View |
| 2024-11-08 Option Award | 2024-11-12 4:15 pm | N/A 2034-11-07 | Keros Therapeutics Inc. | KROS | CHYUNG YUNG H. Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 4:11 pm | N/A 2034-06-02 | Keros Therapeutics Inc. | KROS | BIENAIME JEAN JACQUES Director | 17,600 | $0 | 17,600 (Direct) | View |
Ownership | 2024-06-05 4:10 pm | N/A N/A | Keros Therapeutics Inc. | KROS | BIENAIME JEAN JACQUES Director | 0 | $0 | 200 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Seth Alpna Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Nussbaum Ran Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | GRAY MARY ANN Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-23 5:07 pm | N/A 2034-02-22 | Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:41 pm | N/A 2034-02-12 | Keros Therapeutics Inc. | KROS | Seehra Jasbir CHIEF EXECUTIVE OFFICER | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:40 pm | N/A 2034-02-12 | Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:38 pm | N/A 2034-02-12 | Keros Therapeutics Inc. | KROS | Rovaldi Christopher CHIEF OPERATING OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:37 pm | N/A 2034-02-12 | Keros Therapeutics Inc. | KROS | Cooper Simon Peter CHIEF MEDICAL OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-01-04 Exercise | 2024-01-08 4:43 pm | N/A 2030-04-06 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $0 | 53,622 (Direct) | View |
| 2023-11-04 Exercise | 2024-01-08 4:43 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $16 | 53,622 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 4:13 pm | N/A 2030-04-06 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $0 | 207,244 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 4:13 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $16 | 207,244 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:48 pm | N/A 2033-06-05 | Keros Therapeutics Inc. | KROS | GORDON CARL L Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:47 pm | N/A 2033-06-05 | Keros Therapeutics Inc. | KROS | Seth Alpna Director | 10,000 | $0 | 10,000 (Direct) | View |